IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CANCARINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.621
EU - Europa 7.791
AS - Asia 6.173
SA - Sud America 1.277
Continente sconosciuto - Info sul continente non disponibili 306
AF - Africa 146
OC - Oceania 17
AN - Antartide 1
Totale 30.332
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.319
CN - Cina 2.217
SG - Singapore 2.022
IT - Italia 1.996
PL - Polonia 1.552
UA - Ucraina 1.465
BR - Brasile 1.054
DE - Germania 774
HK - Hong Kong 684
FR - Francia 420
FI - Finlandia 414
VN - Vietnam 366
GB - Regno Unito 356
RU - Federazione Russa 260
TR - Turchia 226
IE - Irlanda 224
IN - India 181
BD - Bangladesh 162
CA - Canada 147
AR - Argentina 69
NL - Olanda 64
MX - Messico 62
SE - Svezia 60
ID - Indonesia 53
BE - Belgio 51
EC - Ecuador 44
IQ - Iraq 43
ZA - Sudafrica 35
NG - Nigeria 34
JP - Giappone 29
CO - Colombia 28
VE - Venezuela 28
ES - Italia 26
PK - Pakistan 26
AT - Austria 25
CZ - Repubblica Ceca 23
IR - Iran 20
PY - Paraguay 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
JM - Giamaica 17
MA - Marocco 17
AU - Australia 16
EG - Egitto 16
LT - Lituania 15
CL - Cile 13
CR - Costa Rica 13
EU - Europa 13
HN - Honduras 13
JO - Giordania 13
KE - Kenya 10
KZ - Kazakistan 10
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
CW - ???statistics.table.value.countryCode.CW??? 8
OM - Oman 8
PR - Porto Rico 8
KR - Corea 7
LB - Libano 7
BG - Bulgaria 6
DZ - Algeria 6
EE - Estonia 6
GT - Guatemala 6
HR - Croazia 6
LV - Lettonia 6
NI - Nicaragua 6
NP - Nepal 6
PH - Filippine 6
UY - Uruguay 6
BO - Bolivia 5
CH - Svizzera 5
ET - Etiopia 5
IL - Israele 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
GP - Guadalupe 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
SV - El Salvador 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
NO - Norvegia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BN - Brunei Darussalam 2
GR - Grecia 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
SC - Seychelles 2
Totale 30.019
Salva come PNG Salva come JPEG
Città #
Warsaw 1.549
Fairfield 1.359
Ashburn 1.320
Woodbridge 1.152
Singapore 1.057
Jacksonville 1.051
Houston 794
Hong Kong 680
Ann Arbor 618
San Jose 596
Chandler 593
Cambridge 591
Seattle 506
Wilmington 464
The Dalles 441
Beijing 427
Princeton 419
Council Bluffs 372
Nanjing 370
New York 301
Dallas 247
Milan 226
Dublin 220
Helsinki 212
Istanbul 188
Los Angeles 186
Lauterbourg 184
Columbus 174
Nanchang 137
Ho Chi Minh City 132
Munich 125
Rome 123
Dearborn 114
Buffalo 108
Des Moines 107
Brescia 105
São Paulo 98
Hebei 82
Moscow 81
Shenyang 79
Jiaxing 77
Changsha 75
San Diego 74
Santa Clara 74
Tianjin 72
Hanoi 66
Chicago 57
Jinan 53
Shanghai 53
Verona 50
Toronto 49
Redondo Beach 48
Brussels 47
Dong Ket 44
London 43
Naples 43
San Francisco 41
Kunming 40
Orem 40
Boardman 38
Phoenix 38
Atlanta 36
Abuja 34
Chennai 34
Florence 33
Brooklyn 32
Hangzhou 32
Turin 32
Rio de Janeiro 31
Lanzhou 28
Frankfurt am Main 27
Mexico City 27
Belo Horizonte 26
Tokyo 26
Stockholm 25
Ningbo 24
Lancaster 23
San Mateo 23
Turku 23
Bologna 22
Denver 22
North Bergen 22
Nuremberg 22
Jakarta 21
Palermo 21
Zhengzhou 21
Augusta 20
Brno 20
Bergamo 19
Brasília 19
Curitiba 19
Falls Church 19
Guangzhou 19
Genoa 18
Monmouth Junction 18
Montreal 18
Charlotte 17
Quito 17
Amsterdam 16
Baghdad 16
Totale 19.632
Salva come PNG Salva come JPEG
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 1.271
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 516
Incremental peritoneal dialysis: a 10 year single-centre experience 332
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 320
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 311
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 289
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 272
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 270
Low-protein diets for chronic kidney disease patients: The Italian experience 268
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 265
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 261
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 261
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 259
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 255
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 247
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 246
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 244
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 220
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 212
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 203
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 202
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 198
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 195
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 195
The MEST score provides earlier risk prediction in lgA nephropathy 194
A more tubulocentric view of diabetic kidney disease 193
Nutritional treatment of advanced CKD: twenty consensus statements 192
Vascular access in older patients: an Italian survey. 192
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 186
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 186
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 186
Differing dialysis treatment strategies and outcome. 183
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 182
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 182
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 180
A six year comparison of patient and technique survivals in CAPD and HD 179
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 178
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 178
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 178
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 176
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 174
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 173
TRANSUDATIVE PLEURAL EFFUSION DUE TO PLEUROPERITONEAL COMMUNICATION IN PERITONEAL DIALYSIS PATIENTS WITH POLYCISTIC KIDNEY DISEASE 170
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 167
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 167
A competing risks model with a time dependent variable: the effects of hypertension onset in the comorbidities history in type 2 diabetes 166
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 166
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 165
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 163
PERITONITE IN DP: CONFRONTO TRA METODICHE 161
Clinical policies on the management of chronic kidney disease patients in Italy. 159
Which vascular access for chronic hemodialysis in uremic elderly patients? 157
Assessment of calcemic status in dialyzed uraemic patients. 156
Adeguatezza del trattamento dialitico: aspetti pratici. 153
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 153
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 153
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 151
Experience with cyclosporine. 151
MALNUTRITION INFLAMMATION SCORE AND RISK OF HOSPITALISATION AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS. 151
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 150
Porphyria and pseudo-porphyria in hemodialyzed patients. 148
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 148
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 148
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 147
Myocardial ultrasound tissue characterization in patients with chronic renal failure 147
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 147
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 147
PERITONITE IN DP: DIABETICI vs. NON-DIABETICI 147
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 145
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 145
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 145
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 144
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 144
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 144
Dialysis initiation: what's the rush? 143
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 142
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 141
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 141
Diethylene Glycol Poisoning From Transcutaneous Absorption 140
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 140
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 140
Porphyria cutanea tarda in a haemodialysed patient. 139
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 139
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 139
Transplantation outcome in patients PD and HD 138
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 138
PD or not PD? That is the question. 137
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 137
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 136
Management of hypertension in chronic renal failure. 136
Is cyclosporine-induced chronic nephrotoxicity inevitable? 134
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 134
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 134
Strategy for preventing peritoneal dialysis failure. 133
Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. 133
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 133
Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment 132
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics 131
Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients. 131
A comparison between continuous ambulatory and automated peritoneal. 130
Totale 19.060
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.235 0 0 0 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20253.634 50 78 44 363 486 291 368 150 431 264 670 439
2025/20266.481 563 864 678 952 528 455 896 238 407 510 267 123
2026/20272.243 425 339 585 894 0 0 0 0 0 0 0 0
Totale 30.332